Searched for
METFORMIN 500
Lupin launches generic anti-diabetic tablets in USPharma major Lupin has launched its generic anti-diabetic medicine in the United States. The medicine is dapagliflozin and metformin hydroc...- Pharma exports fall to five-year low in March amid West Asia crisisIndia's pharma exports saw a sharp 23.17% fall in March. The West Asia war disrupted shipping routes and air transit hubs. This led to incr...
- Diabetes drug Metformin you pop every morning not just impacts blood sugar level, but also affects your brainDiabetes drug Metformin not just impacts your blood sugar level but also affects your brain activity by shutting down a protein called Rap1...
- Pregnant women can soon take anti-diabetes drug MetforminThe UK and some EU countries allow this drug for pregnant women and during the periconceptional phase. So far, doctors in India prescribe i...
- Costs of 127 medicines set to go down post NPPA's 5th price capAmong the 127 medications on the NPPA's list are paracetamol, amoxycillin, rabeprazole, and metformin. Patients frequently make use of many...
- Glenmark launches unique fixed dose combination drug for diabetesThe Mumbai based drug firm said it has introduced fixed dose combination (FDC) of its novel, patent protected Sodium Glucose Co-Transporter...
- Granules gets American drug regulator's nod for diabetes management drug MetforminThe US Food and Drug Administration (USFDA) has granted final approval for the company's abbreviated new drug application (ANDA) for Metfor...
- Lupin, Granules India recall around 9.71 lakh bottles of diabetes drug in the US marketAs per the latest Enforcement Report of the US Food and Drug Administration (USFDA), Lupin is recalling 4,92,858 bottles of Metformin Hydro...
- Alembic Pharma gets tentative nod from USFDA for type-2 diabetes management drugAlembic Pharma said it is currently in litigation with Boehringer Ingelheim in District Court of Delaware and launch of the product will de...
- Lupin recalls diabetes treatment drug in USDrug major Lupin Ltd on Wednesday said it is voluntarily recalling its diabetes treatment drug Metformin Hydrochloride extended-release tab...
- Marksans Pharma recalls 11,279 bottles of diabetes drug due to cancer causing chemicalThe company has issued voluntary recall of one batch of Metformin extended release tablets (USP 500 mg) due to detection of NDMA (N-nitroso...
- Glenmark Pharma gets USFDA nod for diabetes management drug"Glenmark Pharmaceuticals Inc, USA, has been granted final approval by the United States Food & Drug Administration (USFDA) for metformin h...
- Sun Pharma recalls over 2,500 bottles of diabetes drug from USThe reason for recall is presence of foreign substance- one lot of these tablets contains foreign matter identified as a piece of rubber gl...
- Zydus Cadila gets USFDA nod for anti-diabetics tabletsDrug firm Zydus Cadila has received final nod from the US health regulator to sell anti-diabetics Glyburide and Metformin Hcl tablets in th...
- Lupin launches generic diabetes drug in the USLupin has launched 10 products in the US this fiscal year and has received approvals for 21 from the FDA. The drug maker has 35 FTF product...
- Lupin gets USFDA nod for diabetes drugLupin has received US health regulator's approval to sell its generic version of Glumetza HCl ER Tablets in US market.
- Aurobindo Pharma gets USFDA nod for generic Metformin tabletsAurobindo Pharma has received final approval from the USFDA to manufacture and market Metformin Hydrochloride tablets used for treating dia...
- Lupin gets USFDA approval for diabetes drugLupin today said it has received approval from the US health regulator for its Metformin Hydrochloride Extended Release tablets, used in tr...
- Ranbaxy gets USFDA nod for diabetic drugDrug maker Ranbaxy's wholly-owned US subsidiary receives USFDA approval to market Metformin Hydrochloride tablets.
- Aurobindo to market diabetes drug in S AfricaAfter USA, Aurobindo Pharma is all set to market its diabetes drug Metformin tablets in South Africa, as it has received marketing authoris...
Load More
